Paradigm Asset Management’s Haemonetics HAE Stock Holding History

Paradigm Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,800	Closed	-$81.2K	–	698
2016 Q2	$81.2K	Buy	+2,800	New	+$84.6K	0.01%	495
2014 Q3	–	Sell	-3,550	Closed	-$125K	–	812
2014 Q2	$125K	Sell	3,550 -5,600	-61%	-$187K	0.02%	543
2014 Q1	$298K	Hold	9,150	–	–	0.04%	429
2013 Q4	$385K	Hold	9,150	–	–	0.06%	365
2013 Q3	$365K	Sell	9,150 -57,850	-86%	-$2.43M	0.06%	362
2013 Q2	$2.77M	Buy	+67,000	New	+$2.71M	0.48%	64

Other funds holding HAE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Paradigm Asset Management's HAE Position: Q3 2016 in Review

Paradigm Asset Management sold out of Haemonetics (HAE) in Q3 2016, closing a stake of 2,800 shares — an estimated $81.2K sold.

Paradigm Asset Management first reported a position in HAE in Q2 2013 and held it in 6 quarters. The position peaked at $2.77M in Q2 2013. 180 funds tracked by Wall St. Rank hold HAE as of Q3 2016.

Paradigm Asset Management reported no remaining Haemonetics position as of Q3 2016 after selling out during the quarter.
Paradigm Asset Management sold 2,800 Haemonetics shares in Q3 2016, an estimated $81.2K.
Paradigm Asset Management first reported a position in Haemonetics in Q2 2013 and held it in 6 quarters.
Paradigm Asset Management's Haemonetics position peaked at $2.77M in Q2 2013.
180 funds tracked by Wall St. Rank held Haemonetics as of Q3 2016.

Based on Paradigm Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.